Skip to content

Signos — Glucose monitoring app for weight management

Recently funded· $20M Series C· May 27, 2026

Signos makes an FDA-cleared, over-the-counter continuous glucose monitoring app that turns biosensor data into personalized insights for weight management. The California-based company pairs Dexcom CGM hardware with an AI engine that helps non-diabetic users link food, activity, and metabolic response, and is sold direct-to-consumer through Dexcom's Stelo channel.

Get it by email

Companies like Signos go out every weekday morning. One-click unsubscribe.

Round
$20M Series C
Investors
Gv, Blue Cross Blue Shield of Alabama, Dexcom Ventures
Logged
May 27, 2026
Investor

Gv also backed Blacksmith, Odyssey AI, Verse

There is more of this every weekday.